BioSpace News Archive

Business

Sanofi Streamlines Pipeline Focus While Looking Ahead to a Post-COVID-19 World

Despite the bleak challenges brought on by COVID-19, Bill Sibold, executive vice president of Sanofi Genzyme, is optimistic that some of the greatest discoveries in medicine and treating various diseases are within the grasp of the pharmaceutical industry.

June 26, 2020
·
4 min read
·
Alex Keown
Drug Development

Clinical Catch-Up: June 22-26

It was a busy week for clinical trial updates. Here’s a look.

June 26, 2020
·
7 min read
·
Mark Terry
Business

Draper’s Organ-on-a-Chip Platform Multiplexes Tissue Studies for Coronavirus and Flu

The lung model in Draper’s new organ-on-a-chip platform, PREDICT96, replicates the structure and function of human lung tissue from donors with multiple patient profiles on a 96-well plate, increasing assay throughput by 10-fold.

June 26, 2020
·
5 min read
·
Gail Dutton
Drug Development

Moderna Partners with Catalent to Deepen COVID-19 Manufacturing Capabilities

With Moderna on the precipice of launching its Phase III trial of 30,000 people for its COVID-19 vaccine, mRNA-1273, it is ramping up manufacturing capabilities.

June 26, 2020
·
3 min read
·
Mark Terry
FDA

Zogenix Wins Approval for Dravet Syndrome Treatment Fintepla

Shares of Zogenix were up more than 16% in premarket trading following the regulatory approval of the epilepsy drug Fintepla for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy, in patients ages two and above.

June 26, 2020
·
2 min read
·
Alex Keown
FDA

Allergan/AbbVie’s Macular Degeneration Drug Abicipar Pegol Rejected by FDA

The U.S. Food and Drug Administration issued a Complete Response Letter, a rejection, of Allergan’s Biologics License Application for Abicipar pegol for neovascular age-related macular degeneration.

June 26, 2020
·
3 min read
·
Mark Terry
Policy

Vaxart’s COVID-19 Vaccine Candidate Tapped for Operation Warp Speed Primate Study

One month after Vaxart announced the selection of its lead vaccine candidate for COVID-19, the Bay Area-based company said it has been selected to participate in the U.S. government’s Operation Warp Speed program.

June 26, 2020
·
2 min read
·
Alex Keown
Policy

ERC Belgium Submits Marketing Authorization Application to European Medicines Agency (EMA) for Glioblastoma Immunotherapy, SITOIGANAP

ERC Belgium, a clinical-stage biopharmaceutical company developing immunotherapies for the treatment of cancer, has announced that it has submitted to the EMA its Marketing Authorization Application for conditional approval of its lead product SITOIGANAP to treat recurrent glioblastoma.

June 26, 2020
·
3 min read
Pediatric Medical Devices Market: Rise in Newborn Deaths due to Chronic Diseases to Create Opportunities for the Market

Transparency Market Research has published a new report titled, “Pediatric Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

June 26, 2020
·
6 min read
Metastatic Bone Disease Market: Rise in incidence rate of cancer across the world is a major driving factor

Transparency Market Research has published a new report titled, “Metastatic Bone Disease Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

June 26, 2020
·
4 min read